Commerce and Insurance, Dept. of - As enacted, revises law relative to the treatment and coverage of treatment for stage 4 advanced metastatic cancer, blood cancer, metastatic blood cancer, and associated conditions; makes related changes. - Amends TCA Title 8; Title 56; Title 63; Title 68 and Title 71.

SB 1382 requires Tennessee's Commerce and Insurance Commissioner to study whether insurers' online processes for step therapy exceptions (where patients must try cheaper treatments first) are easy for patients and doctors to use. The study specifically examines if insurers comply with state law without creating unnecessary barriers for requesting exceptions, particularly for conditions like advanced cancer. The commissioner must report findings and recommendations to lawmakers by December 15, 2025. This bill affects patients and healthcare providers seeking coverage for treatments that require step therapy exceptions, but it does not change coverage rules - only studies current processes.